Human KB carcinoma cells were selected in sequential steps for resistance to colchicine and found to be cross-resistant to multiple drugs, including vinblastine, adriamycin, and actinomycin D. Compared with the parental line, the multiply resistant cells have decreased amounts of two [35S]methionine-labeled proteins with apparent molecular masses of 75 and 72 kDa. These proteins reappear in a revertant, drug-sensitive cell line. Both proteins are labeled with [14ClglucosaMine and are retained on a wheat germ agglutinin-agarose column, indicating that they are glycoproteins. These data suggest that in this human cell line, these two glycoproteins can serve as a marker of the multiple drug-resistance phenotype and may play a role in its etiology.
One of the major obstacles to effective cancer chemotherapy is the development of drug resistance, especially resistance to multiple chemotherapeutic agents. To understand the mechanism of multiple drug resistance, several laboratories have developed drug-resistant sublines of mammalian cells. Ling and co-workers (1, 2) isolated multiply drug-resistant Chinese hamster ovary cells and found a correlation between drug resistance and increased expression of a 170-kDa surface protein, termed P-glycoprotein (3) (4) (5) (6) . Multiply drug-resistant Chinese hamster lung cells isolated by Biedler and coworkers (7, 8) have increased amounts of a 150-kDa membrane glycoprotein and altered gangliosides. Beck et al. (9,  10) have isolated a human lymphoblastoid cell line resistant to multiple drugs that has increased expression of a 170-kDa cell surface glycoprotein.
We recently isolated a series of multiply drug-resistant mutants of human KB epidermoid carcinoma cells by stepwise selection in colchicine (11) . These mutants are crossresistant to vincristine, vinblastine, adriamycin, actinomycin D, and puromycin and also show decreased accumulation of these unrelated drugs (12) . Cell-cell hybridization experiments show that the colchicine-resistant phenotype and the multiply drug-resistant phenotype are incompletely dominant (11) . In the current study, we report that two glycoproteins (72 and 75 kDa) are substantially decreased and nearly absent in drug-resistant cell lines that are 128-fold and 800-fold more resistant to colchicine than the parent cell line. These Staphylococcus aureus was prepared as described (13) . Reagents for gel electrophoresis were from Bio-Rad.
Cell Lines. The parent cell line KB-3-1 was established from a single clone of KB human carcinoma cells (11) . The drug-resistant subline KB-ChR-8-5-11-24 (where ChR = colchicine-resistant) was derived from KB-3-1 by a series of step selections in colchicine (11) . This mutant, hereafter designated KB-ChR-24, was maintained in medium containing colchicine at 1 Ag/ml. The KB-C2.5 cell line was isolated from KB-ChR-24 and represents a cell population that survived stepwise increases in colchicine from 1 ,ug/ml to 2.5 ,ug/ml. KB-C2.5 cells were maintained in medium containing colchicine at 2.5 pug/ml. The KB-Al revertant was isolated as a spontaneous revertant of KB-ChR-24 after subcloning twice in the absence of colchicine. (14) and centrifuged at 1000 rpm (5 min). The cell pellet was homogenized in 3 ml of hypotonic buffer (20 mM sodium phosphate, pH 7.0/10 mM NaCl/1 mM EDTA/1% aprotinin) by using a tight-fitting Dounce homogenizer (100 strokes). The homogenate was first centrifuged at 1000 rpm 
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fuged at 100,000 x g (30 min). The 100,000 x g pellet was extracted with 3 ml of modified RIPA buffer, clarified of insoluble material at 100,000 x g (30 min), and applied to a 2-ml column of wheat germ agglutinin-agarose by using the conditions described (18) . Bound proteins were eluted with 0.3 M N-acetylglucosamine in column buffer (50 mM Hepes, pH 7.4/0.5 M NaCl/0.1% Triton X-100). The eluate from the wheat germ agglutinin column was next applied to a 1-ml column of DEAE-Sephacel equilibrated in 50 mM NaCl in column buffer (20 mM Tris HCl), pH 7.4/0.1% Triton X-100/1 mM EDTA/1% aprotinin). Prior to loading, the sample was diluted 1:3 (vol/vol) with column buffer to reduce the ionic strength of the sample. After collecting the flowthrough fraction, the column was washed with 20 vol of 50 mM NaCl in column buffer. Bound proteins were eluted with a 30-ml linear gradient of NaCl (50 mM-i M) in column buffer. 1 ). As reported (11) , in KB-ChR-24, no major differences were detected. However, in the highly resistant KB-C2.5 subline, it appeared that one or more bands in the 70-to 75-kDa region were diminished. In the revertant cell line KB-24-Ri these proteins reappeared. No protein bands were increased.
Because of our interest in KB cells we had previously produced several polyclonal and monoclonal antibodies to these cells. One of the polyclonal antisera, no. 8747, immunoprecipitated two proteins in the 70-kDa range as well as a 92-kDa and a 36-kDa protein (ref. 16 and Fig. 2, lane 1) . Other minor bands were evident on longer exposures. Both the 75-kDa and the 72-kDa protein bands were diminished in KB-ChR-24 cells and nearly absent in KB-C2.5 cells (Fig. 2, lanes 2 and   3) . In the revertant cell line (KB-24-R1) both proteins reappeared at nearly normal levels (Fig. 2, lane 4) . The bands at 92 kDa and 36 kDa remained unchanged in all cell lines. The 92-kDa protein has been identified as the transferrin receptor because of its molecular mass and because 1251-labeled transferrin is immunoprecipitated together with the 92-kDa (13) .
Both the 75-kDa and 72-kDa proteins can be labeled with
[14C]glucosamine (Fig. 2, lanes 5-8) . In KB-ChR-24 cells, the 72-kDa band is diminished. In KB-C2.5 cells both bands are absent but a new band appears above the position of the 75-kDa band with an apparent molecular mass of 76 kDa. The revertant KB-24-Rl has a pattern similar to the parental cell line KB-3-1.
To determine the subcellular localization of the 72-kDa and 75-kDa glycoproteins, a homogenate of [35S]methioninelabeled KB-3-1 cells was subjected to differential centrifugation. The various fractions were immunoprecipitated with the polyclonal rabbit serum and analyzed by NaDodSO4/ PAGE. Fig. 3 shows that both glycoproteins are quantitatively recovered from the 100,000 x g pellet fraction after extraction with modified RIPA buffer.
Partial purification of the 72-kDa and 75-kDa glycoproteins is shown in Figs. 3 and 4 . The modified RIPA extract from the 100,000 x g pellet fraction was applied to a column of wheat germ agglutinin-agarose, and 80% of the radioactivity was found in the flow-through fraction of the column. After extensive washing, the bound material (4% of the total radioactivity) was eluted with 0.3 M N-acetylglucosamine. Immunoprecipitation of the flow-through fraction and bound material revealed that the 75-kDa and 72-kDa proteins were bound to the column and eluted with N-acetylglucosamine (Fig. 3 ). This step resulted in a 15-fold purification of both glycoproteins, with a 56% recovery. methionine-labeled KB-3-1 cells were prepared by differential centrifugation and 100-,ul aliquots were immunoprecipitated with preimmune rabbit serum (-) or with rabbit antiserum no. 8747 (+). The homogenate was centrifuged at 600 x g for 5 min to generate a lowspeed pellet (LSP). The 600 x g supernatant was centrifuged at 100,000 x g (30 min) to generate a high-speed supernatant (HSS) and high-speed pellet (HSP). The pellet fractions were extracted with 3 ml of modified RIPA buffer and clarified at 100,000 x g prior to immunoprecipitation. (Right) The modified RIPA extract of the HSP fraction (Left) was applied to a 1-ml column of wheat germ agglutinin-agarose. The flow-through fraction (FT) contained 80%o of the total cpm applied (14 x 106 cpm), and the retained material (6.5 x 101 cpm) was eluted with 0.3 M N-acetylglucosamine. Aliquots (100 ,ul) of the FT and retained material were immunoprecipitated. Chromatography on DEAE-Sephacel of the wheat germ agglutinin-agarose eluate column is shown in Fig. 4A . The fractions were analyzed by NaDodSO4/PAGE before (Fig.  4B) and after (Fig. 4C) Ab 40 4.w of decreased amounts of these proteins in the drug-resistant cells. Electrophoresis on NaDodSO4/polyacrylamide gels without prior reduction by 2-mercaptoethanol did not change the relative mobilities of the 75-kDa and 72-kDa polypeptides, indicating that they are not disulfide-linked.
DISCUSSION
In the present study we show a major decrease in the levels of two glycoproteins of apparent molecular masses 75 kDa and 72 kDa in multiply drug-resistant human KB cells. The decrease in the proteins parallels thle level of drug resistance; both protein bands reappear in a revertant that has regained almost normal drug sensitivity. These findings suggest that the decrease in these proteins may have an important role in the development of resistance to multiple drugs. A decrease in a 75,000-to 85,000-dalton cell surface glycoprotein has also been reported by Beck et al. (9) in vinblastine-resistant CEM cells.
Because KB-ChR-24 cells show both decreased drug uptake and increased drug release (12) , there are many possible roles for these proteins. One simple hypothesis is that they are required for drug entry and their decrease results in impaired drug uptake. Alternatively, they could be required for drug retention and their loss results in increased drug release.
Previous investigators have reported increased levels of a 170-kDa glycoprotein designated P-glycoprotein (3-6) and a 150-kta glycoprotein (7, 8) . To look for these glycoproteins in KB-ChR-24, a polyclonal antiserum was prepared against the P-glycoprotein of Chinese hamster ovary cells, but it did not detect an increase in KB-ChR-24 cells (data not shown). Additionally, a monoclonal antibody (no. 115) that reacts with a family of four structurally related glycoproteins of 110 kDa, 130 kDa, 150 kDa, and 200 kDa detects enhanced levels of the high molecular mass forms in KB-ChR-24 cells, but the changes persist in the drug-sensitive revertant cell line (unpublished results).
Although the major finding in the present study was decreased levels of the 72-kDa and 75-kDa proteins, we also noted accumulation of a 76-kDa protein that was highly glycosylated and poorly labeled with [35S]methionine (Fig. 2,  lane 7) . The relationship of the 76-kDa protein to the other two is unclear. It could be a more glycosylated form of the lower molecular mass polypeptides or an unrelated glycoprotein detected by this polyclonal antiserum. The presence of such an abnormal protein could contribute to the drugresistant phenotype as could other changes not detected in the current study.
The present study leaves many questions unanswered. One is the relationship of the 75-kDa and 72-kDa proteins to each other. The 75-kDa protein may be a more highly glycosylated form of the 72-kDa protein or the proteins may be unrelated. A second important question is whether the decreased expression of these twq proteins can account for multiple drug resistance in some human cancers. Monoclonal antibodies to these proteins have been prepared that should help clarify these and other questions.
